HK1130186A1 - Phospholipid analogue for the in vivo diagnosis of cancers - Google Patents
Phospholipid analogue for the in vivo diagnosis of cancersInfo
- Publication number
- HK1130186A1 HK1130186A1 HK09109089.4A HK09109089A HK1130186A1 HK 1130186 A1 HK1130186 A1 HK 1130186A1 HK 09109089 A HK09109089 A HK 09109089A HK 1130186 A1 HK1130186 A1 HK 1130186A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancers
- vivo diagnosis
- phospholipid analogue
- phospholipid
- analogue
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 150000003904 phospholipids Chemical class 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- -1 phospholipid ether analogs Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0408—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52116604P | 2004-03-02 | 2004-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1130186A1 true HK1130186A1 (en) | 2009-12-24 |
Family
ID=34919310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09109089.4A HK1130186A1 (en) | 2004-03-02 | 2009-09-30 | Phospholipid analogue for the in vivo diagnosis of cancers |
Country Status (17)
Country | Link |
---|---|
US (3) | US8535641B2 (de) |
EP (3) | EP1729824B1 (de) |
JP (7) | JP2007528374A (de) |
KR (1) | KR20070015518A (de) |
CN (1) | CN1929869B (de) |
AT (1) | ATE437657T1 (de) |
AU (1) | AU2005219412A1 (de) |
BR (1) | BRPI0508425A (de) |
CA (1) | CA2557698A1 (de) |
DE (1) | DE602005015687D1 (de) |
DK (1) | DK1729824T3 (de) |
ES (3) | ES2330951T3 (de) |
HK (1) | HK1130186A1 (de) |
IL (1) | IL177645A0 (de) |
MX (1) | MXPA06009681A (de) |
WO (1) | WO2005084716A2 (de) |
ZA (1) | ZA200607042B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2330951T3 (es) | 2004-03-02 | 2009-12-17 | Cellectar, Inc. | Analogos de fosfolipido para el tratamiento de canceres. |
US8540968B2 (en) * | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
WO2006014589A2 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
CA2591907A1 (en) * | 2004-12-20 | 2007-02-01 | Cellectar, Llc | Phospholipid ether analogs for detecting and treating cancer |
CA2660778A1 (en) * | 2006-08-15 | 2009-01-08 | Cellectar, Inc. | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
US8022235B2 (en) | 2007-06-01 | 2011-09-20 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
US7893286B2 (en) | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
US20110184283A1 (en) * | 2008-07-25 | 2011-07-28 | Tufts Medical Center | system and method of clinical treatment planning of complex, monte carlo-based brachytherapy dose distributions |
US8871181B2 (en) | 2009-05-11 | 2014-10-28 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
ES2549459T3 (es) * | 2009-05-11 | 2015-10-28 | Cellectar, Inc. | Compuestos de éter de fosfolípido fluorescentes, composiciones y procedimientos de uso |
US7811548B1 (en) | 2009-05-11 | 2010-10-12 | Cellectar, Inc. | Fluorescent phospholipid ether compounds and compositions |
RU2012100765A (ru) | 2009-06-12 | 2013-07-20 | Селлектар, Инк. | Эфирные и алкильные фосфолипидные производные для лечения рака и визуализации и детектирования раковых стволовых клеток |
US10007961B2 (en) * | 2009-09-09 | 2018-06-26 | Wisconsin Alumni Research Foundation | Treatment planning system for radiopharmaceuticals |
RU2012114146A (ru) * | 2009-09-11 | 2013-10-20 | Селлектар, Инк. | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения |
EP3229810B1 (de) | 2014-11-17 | 2020-07-22 | Cellectar Biosciences, Inc. | Phospholipidetheranaloga als auf krebs abzielende arzneimittelträger |
AU2016349577B2 (en) | 2015-11-06 | 2023-10-26 | Wisconsin Alumni Research Foundation | Long-lived gadolinium based tumor targeted imaging and therapy agents |
BR112018077197A2 (pt) * | 2016-06-14 | 2019-08-20 | Pinchuk Anatoly | análogos de éter de fosfolipídio para identificação e isolamento de células tumorais circulantes |
US11147823B2 (en) * | 2016-07-13 | 2021-10-19 | Wisconsin Alumni Research Foundation | Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors |
WO2018017526A1 (en) | 2016-07-18 | 2018-01-25 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for in situ immune modulated cancer vaccination |
US10751430B2 (en) * | 2016-07-25 | 2020-08-25 | Wisconsin Alumni Research Foundation | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
KR102332958B1 (ko) * | 2016-07-25 | 2021-11-29 | 위스콘신 얼럼나이 리서어치 화운데이션 | 암 영상화 및 치료를 위한 방사성 인지질 금속 킬레이트 |
EP3579870A4 (de) | 2017-02-07 | 2020-12-30 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | Auf car-t-zell-tumor (ctct) abzielende phospholipidether (ple)-wirkstoffe |
JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Car t細胞療法のための組成物および方法 |
WO2019094657A1 (en) * | 2017-11-10 | 2019-05-16 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (trt) to drive anti-tumor immune response to immunotherapies |
US20190184040A1 (en) * | 2017-12-15 | 2019-06-20 | Wisconsin Alumni Research Foundation | Targeted Macrocyclic Agents for Dual Modality PET and MRI Imaging of Cancer |
US11779602B2 (en) | 2018-01-22 | 2023-10-10 | Endocyte, Inc. | Methods of use for CAR T cells |
BR112020015884A2 (pt) * | 2018-02-06 | 2020-12-08 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Receptores de antígeno quimérico (cars) específicos de fluoresceína exibindo a função de célula t ótima contra os tumores marcados por fl-ple |
MX2022004341A (es) * | 2019-10-10 | 2022-08-10 | Cellectar Biosciences Inc | Conjugados de fosfolípido-flavaglina y métodos para usar los mismos para la terapia dirigida al cáncer. |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5851526A (en) * | 1985-04-19 | 1998-12-22 | Ludwig Institute For Cancer Research | Methods of treating colon cancer utilizing tumor-specific antibodies |
US4873075A (en) * | 1985-09-10 | 1989-10-10 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
US5093042A (en) * | 1985-09-10 | 1992-03-03 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
US4957729A (en) * | 1985-09-10 | 1990-09-18 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
US4925649A (en) | 1987-06-12 | 1990-05-15 | The University Of Michigan | Radioiodinated diacylglycerol analogues and methods of use |
US5087721A (en) | 1987-10-23 | 1992-02-11 | The University Of Michigan | Radioiodinated phosphate esters |
US4965391A (en) | 1987-10-23 | 1990-10-23 | The University Of Michigan | Radioiodinated phospholipid ether analogues |
US5347030A (en) * | 1987-10-23 | 1994-09-13 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues and methods of using same |
US5041859A (en) * | 1988-10-04 | 1991-08-20 | Nikon Corporation | Automatic focusing detection device for cameras |
US5274113A (en) | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
US5369097A (en) * | 1991-04-25 | 1994-11-29 | The University Of British Columbia | Phosphonates as anti-cancer agents |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5626654A (en) * | 1995-12-05 | 1997-05-06 | Xerox Corporation | Ink compositions containing liposomes |
CA2276284C (en) | 1996-12-04 | 2006-10-10 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
US6255519B1 (en) | 1996-12-04 | 2001-07-03 | Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
US6503478B2 (en) * | 1999-01-13 | 2003-01-07 | Lightouch Medical, Inc. | Chemically specific imaging of tissue |
PT1200117E (pt) * | 1999-06-24 | 2008-11-26 | Univ British Columbia | Tratamento à base de variantes da lipoproteína lipase |
AU2002225772A1 (en) * | 2000-11-27 | 2002-06-03 | Praecis Pharmaceuticals Inc. | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
DK1404319T3 (da) * | 2001-06-06 | 2006-07-31 | Brookhaven Science Ass Llc | Hidtil ukendte metalloporphyriner og anvendelsen deraf som radiosensibilisatorer til strålebehandling |
US7220539B1 (en) * | 2002-06-12 | 2007-05-22 | The Salk Institute For Biological Studies | Protein kinase B/Akt modulators and methods for the use thereof |
CA2489469C (en) * | 2002-06-14 | 2016-03-22 | Immunomedics, Inc. | Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
CA2492878A1 (en) * | 2002-07-19 | 2004-01-29 | Ludwig Institute For Cancer Research | Enhancing the effect of radioimmunotherapy in the treatment of tumors |
EP1670946B1 (de) | 2003-09-19 | 2012-11-07 | bioTheranostics, Inc. | Vorhersage des ausgangs einer brustkrebsbehandlung |
US7829742B2 (en) | 2003-12-22 | 2010-11-09 | Johns Hopkins University | Boronic acid aryl analogs |
ES2330951T3 (es) | 2004-03-02 | 2009-12-17 | Cellectar, Inc. | Analogos de fosfolipido para el tratamiento de canceres. |
US8540968B2 (en) * | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
US7632644B2 (en) * | 2004-03-02 | 2009-12-15 | Cellectar, Inc. | Imaging and selective retention of phospholipid ether analogs |
WO2006014589A2 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
EP1729790A4 (de) * | 2004-03-29 | 2009-09-30 | Robin Polt | Amphipathische glycopeptide |
US20060115426A1 (en) * | 2004-08-11 | 2006-06-01 | Weichert Jamey P | Methods of detecting breast cancer, brain cancer, and pancreatic cancer |
US7041859B1 (en) | 2004-09-09 | 2006-05-09 | University Of Tennessee Research Foundation | Method for halogenating or radiohalogenating a chemical compound |
CA2591907A1 (en) * | 2004-12-20 | 2007-02-01 | Cellectar, Llc | Phospholipid ether analogs for detecting and treating cancer |
CA2660778A1 (en) * | 2006-08-15 | 2009-01-08 | Cellectar, Inc. | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
US7893286B2 (en) * | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
US8022235B2 (en) * | 2007-06-01 | 2011-09-20 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
GB0819280D0 (en) | 2008-10-21 | 2008-11-26 | Gen Electric | Imgaing and radiotherapy methods |
RU2012100765A (ru) | 2009-06-12 | 2013-07-20 | Селлектар, Инк. | Эфирные и алкильные фосфолипидные производные для лечения рака и визуализации и детектирования раковых стволовых клеток |
RU2012114146A (ru) * | 2009-09-11 | 2013-10-20 | Селлектар, Инк. | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения |
WO2011031911A1 (en) * | 2009-09-11 | 2011-03-17 | Cellectar, Inc. | Deuterated alkyl phospholipid compounds, compositions, and methods of use |
-
2005
- 2005-03-02 ES ES05729873T patent/ES2330951T3/es active Active
- 2005-03-02 ES ES08020805T patent/ES2430065T3/es active Active
- 2005-03-02 CN CN2005800070569A patent/CN1929869B/zh active Active
- 2005-03-02 WO PCT/US2005/006681 patent/WO2005084716A2/en active Application Filing
- 2005-03-02 KR KR1020067018488A patent/KR20070015518A/ko not_active Application Discontinuation
- 2005-03-02 AT AT05729873T patent/ATE437657T1/de not_active IP Right Cessation
- 2005-03-02 JP JP2007501917A patent/JP2007528374A/ja not_active Withdrawn
- 2005-03-02 AU AU2005219412A patent/AU2005219412A1/en not_active Abandoned
- 2005-03-02 BR BRPI0508425-3A patent/BRPI0508425A/pt not_active Application Discontinuation
- 2005-03-02 EP EP05729873A patent/EP1729824B1/de active Active
- 2005-03-02 EP EP08020805.1A patent/EP2044961B1/de active Active
- 2005-03-02 US US10/906,687 patent/US8535641B2/en active Active
- 2005-03-02 CA CA002557698A patent/CA2557698A1/en not_active Abandoned
- 2005-03-02 MX MXPA06009681A patent/MXPA06009681A/es active IP Right Grant
- 2005-03-02 ES ES08010321.1T patent/ES2440257T3/es active Active
- 2005-03-02 DE DE602005015687T patent/DE602005015687D1/de active Active
- 2005-03-02 DK DK05729873T patent/DK1729824T3/da active
- 2005-03-02 EP EP08010321.1A patent/EP2044960B1/de active Active
-
2006
- 2006-08-22 IL IL177645A patent/IL177645A0/en unknown
- 2006-08-23 ZA ZA200607042A patent/ZA200607042B/en unknown
-
2009
- 2009-09-30 HK HK09109089.4A patent/HK1130186A1/xx unknown
-
2012
- 2012-01-13 JP JP2012005213A patent/JP2012097113A/ja not_active Withdrawn
- 2012-10-24 JP JP2012234608A patent/JP2013040201A/ja active Pending
-
2013
- 2013-08-12 US US13/964,315 patent/US8877159B2/en active Active
-
2014
- 2014-07-18 JP JP2014147869A patent/JP6228080B2/ja active Active
- 2014-09-30 US US14/501,373 patent/US9550002B2/en active Active
-
2015
- 2015-01-05 JP JP2015000135A patent/JP6342818B2/ja active Active
-
2016
- 2016-07-08 JP JP2016135920A patent/JP6453818B2/ja active Active
-
2017
- 2017-05-31 JP JP2017108141A patent/JP2017173339A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1130186A1 (en) | Phospholipid analogue for the in vivo diagnosis of cancers | |
IL187343A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
HUS1600049I1 (hu) | Bruton tirozinkináz inhibitorok | |
ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1937280A4 (de) | Zusammensetzungen und verfahren zur diagnose und therapie von bcl2-assoziierten tumoren | |
ATE527552T1 (de) | Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe | |
EP1784639A4 (de) | Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren | |
BRPI0607728A2 (pt) | complexo de lipoproteìna carregado reconstituìdo, composição farmacêutica, e, uso de um complexo de lipoproteìna carregado | |
MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
EP1758595A4 (de) | Verwendung von lipidkonjugaten bei der behandlung von erkrankungen | |
EP2359864A3 (de) | Zielender Vektor-Phospholipid Konjugaten | |
IL178435A0 (en) | Beta-carbolines useful for treating inflammatory disease | |
IL189104A (en) | Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders. | |
CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
ZA200510282B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2009076388A3 (en) | Targeting vector-phospholipid conjugates | |
DK1228770T3 (da) | Törret kontrastmiddel | |
AU2003237792A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
GB0207653D0 (en) | Methods of using lamellar bodies for therapeutic purposes | |
EP1611151A4 (de) | Stq-peptide | |
PL1606233T3 (pl) | Estry fosfolipidowe klofarabiny | |
IL185653A (en) | Antibodies that call for the 1-kim salt region | |
EP1797430A4 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von krebs | |
IL185900A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
ZA200604365B (en) | Compositions and methods for the diagnosis and treatment of tumor |